Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Here's Why the Best Is Yet to Come for Opko Health Inc.
Here's Why the Best Is Yet to Come for Opko Health Inc.
There's not a whole lot that looks good for Opko Health Inc. (NASDAQ: OPK) right now. The stock has dropped more than 30% so far in 2017. Several large institutional investors have reduced their....
3 Biotech Stocks That Have Already Quadrupled in 2017
3 Biotech Stocks That Have Already Quadrupled in 2017
It's been a good year for biotech stocks, the iShares Nasdaq Biotechnology index has risen about 26% this year but a handful of companies make the industry tracking index's success seem trivial.....
Why Shares of Inovalon Are Soaring Today
Why Shares of Inovalon Are Soaring Today
Shares of cloud-based healthcare platform provider Inovalon (NASDAQ: INOV) jumped on Tuesday after the company announced that UnitedHealthcare, a business of UnitedHealth Group (NYSE: UNH), had....
Here's Why Advaxis, Inc. Stock Is Getting Pummeled Today
Here's Why Advaxis, Inc. Stock Is Getting Pummeled Today
Shares of Advaxis, Inc. (NASDAQ: ADXS), a clinical-stage biotech developing novel cancer immunotherapies, are sinking after the company provided a business update along with a third-quarter....
Why Achillion Pharmaceuticals Crashed 22.2% Today
Why Achillion Pharmaceuticals Crashed 22.2% Today
After Johnson & Johnson (NYSE: JNJ) announced it's ending its agreement to develop Achillion Pharmaceuticals' (NASDAQ: ACHN) hepatitis C drugs, Achillion Pharmaceuticals shares lost 22.2% of....
Allergan's Patent Loophole Could Be a Huge Gift for Pfizer
Allergan's Patent Loophole Could Be a Huge Gift for Pfizer
The tribe has spoken.On Friday, Allergan (NYSE: AGN) announced that the Saint Regis Mohawk Tribe now owns all patents for blockbuster dry-eye disease drug Restatis. Both parties should win from....
Slash Your Medicare Drug Costs With These 6 Tips
Slash Your Medicare Drug Costs With These 6 Tips
IMAGE SOURCE: GETTY IMAGES.If you're one of the millions of Americans with Medicare Part D or Medicare Advantage coverage, or if you're signing up for one of these plans for the first time, then....
2 Dividend Stocks You Can Buy and Hold Forever
2 Dividend Stocks You Can Buy and Hold Forever
If you'd like to park your money in stocks and monitor them as little as possible, you need to choose them extra carefully. There's no guarantee that even today's most successful companies won't....
3 Biotech Stocks That Skyrocketed This Week: Can They Go Higher?
3 Biotech Stocks That Skyrocketed This Week: Can They Go Higher?
Every biotech company goes into a clinical study with great hopes -- and often great fears, as well. There's no guarantee that all will go well. All the time and money poured into an experimental....
Good News for Opdivo Shows Why You Shouldn't Give Up on Bristol-Myers Squibb Stock
Good News for Opdivo Shows Why You Shouldn't Give Up on Bristol-Myers Squibb Stock
Bristol-Myers Squibb (NYSE: BMY) investors might have been just a bit worried on Wednesday. After all, the U.S. Food and Drug Administration (FDA) had just placed a partial clinical hold on three....
Here's Why Spark Therapeutics Inc. Surged 23.5% in August
Here's Why Spark Therapeutics Inc. Surged 23.5% in August
Shares of Spark Therapeutics Inc. (NASDAQ: ONCE), a clinical-stage biotech developing gene therapies, rose 23.5% in August, according to data from S&P Global Market Intelligence. The company....
7 Medical Conditions That Will Be Lining Big Pharma's Pockets by 2020
7 Medical Conditions That Will Be Lining Big Pharma's Pockets by 2020
Image source: Getty Images.Imagine a stack of dollar bills reaching from the ground to more than 95,000 miles into the sky -- nearly four-tenths of the way to the moon. That stack would total $1.4....
The Key Reason Incyte Corporation Added $850 Million in Market Cap in August
The Key Reason Incyte Corporation Added $850 Million in Market Cap in August
Shares of Incyte (NASDAQ: INCY), a large-cap biotech company primarily focused on developing therapies to treat cancer and inflammatory diseases, tacked on more than $4 per share, or $850 million....
Better Buy: Gilead Sciences, Inc. vs. Johnson & Johnson
Better Buy: Gilead Sciences, Inc. vs. Johnson & Johnson
I bought my shares of Johnson & Johnson (NYSE: JNJ) and Gilead Sciences, Inc. (NASDAQ: GILD) long ago, when they were trading far lower than they are today. If I had to choose one to keep and....
Here's the Best Dividend Stock in Big Pharma
Here's the Best Dividend Stock in Big Pharma
Dividends make a huge impact on your overall investing returns. They can also provide solid income during your retirement years. Historically, big pharma stocks have been a great place for....
Better Buy: Eli Lilly and Company vs. Pfizer Inc.
Better Buy: Eli Lilly and Company vs. Pfizer Inc.
Two of the biggest pharmaceutical companies in the world have been around since the 19th century. Eli Lilly and Company (NYSE: LLY) was founded in 1876, while Pfizer Inc. (NYSE: PFE) began....
3 Stocks That Pay You
3 Stocks That Pay You
Other than the obvious reason that investors like the steady stream of income that comes from investing in dividend-paying stocks, the stability it conveys about a particular business provides a....
3 Dividend Stocks That Thrive in Bear Markets
3 Dividend Stocks That Thrive in Bear Markets
One of the benefits of dividend investing is the comfort that comes from the regular income stream. But market downturns can many times throw that sense of security out the window. What income....
Found: 3 Stocks Retirees Should Consider Adding
Found: 3 Stocks Retirees Should Consider Adding
In the hunt for stocks to carry you through your retirement, you're probably looking for low-volatility stocks that supply reliable, steadily rising streams of income. You're past the time....
Why Abeona Therapeutics Inc. (and Maybe Sangamo Therapeutics, Inc.) Jumped Higher Today
Why Abeona Therapeutics Inc. (and Maybe Sangamo Therapeutics, Inc.) Jumped Higher Today
Shares of Abeona Therapeutics (NASDAQ: ABEO) jumped 18.4% on Tuesday, while shares of Sangamo Therapeutics (NASDAQ: SGMO) ended up 11.3%. The former is clearly because Abeona received a....
This Simple Step Can Make Diabetes Patients Healthier -- and Possibly Wealthier
This Simple Step Can Make Diabetes Patients Healthier -- and Possibly Wealthier
If you're one of the millions of Americans diagnosed with diabetes, large pharmacy benefits manager (PBM) Express Scripts (NASDAQ: ESRX) has good news for you. There's something you can do that....
Why Catalent Inc. Rose as Much as 17% This Morning
Why Catalent Inc. Rose as Much as 17% This Morning
Shares of drug-delivery technology specialist Catalent (NYSE: CTLT) jumped as much as 17% Tuesday morning in the wake of the company's 2017 fiscal year earnings report, released Monday after the....
3 Healthcare Stocks to Buy With Dividends Yielding More Than 3%
3 Healthcare Stocks to Buy With Dividends Yielding More Than 3%
There are fewer healthcare stocks with high yields than you might think. At least that's the case depending on your definition of "healthcare stocks" and "high yields." If you think a high-yield....
In Your 60s? 3 Stocks You Might Want to Buy
In Your 60s? 3 Stocks You Might Want to Buy
For many Americans, reaching their 60s is often the point where they transition out of the labor force and into retirement. It means putting that alarm clock to bed for good and putting your feet....
Can Buying Exelixis Stock Still Make You Rich?
Can Buying Exelixis Stock Still Make You Rich?
What were you doing on Friday, Jan. 2, 2015? It's OK if you don't remember. I certainly can't.But there were some investors who did something on that date who probably recall it with a smile.....